PATENT CLAIM ANALYSIS

Application Number: 15991703
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "303000"]

Abstract:
The present disclosure provides, inter alia, Compounds of Formula (I) or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications.

Claim (Index 31):
A pharmaceutical composition comprising a compound of  claim 1  or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 75.0
- Percentile: 93.0
- Lexical Diversity: 1.2381
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15991747', '13947995', '14503198', '12765034', '14887171']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7483017077810069
- 35 USC 102 Novelty (BERT): 0.575160681493889
- Combined Prediction Score: 0.7309876051522951
- Mean Citation Score: 367.032208
- Max Citation Score: 475.89847
- Similarity Product: 373.1137230569732

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test